ISCTM 2022 promotes high-quality development of clinical and translational medicine
The International Symposium on Clinical and Translational Medicine (ISCTM 2022) was held in Shanghai from November 22 to 24, 2022.
The forum was co-hosted by the Chinese Academy of Engineering (CAE) and the Chinese Academy of Medical Sciences, and jointly organized by the CAE Medicine and Health Division, the Shanghai Consulting & Academic Activities Centre for Academicians of Chinese Academy of Engineering, and the Shanghai Research Institute of China Engineering Science and Technology Development Strategy.
ISCTM 2022 featured one high-level international forum, six plenary speeches and six themed subforums. In the event, academicians and experts from both domestic and international institutions held discussions on diverse topics such as chronic disease diagnosis and treatment, development of new drugs, tumor immunology and COVID-19 while also sharing new concepts, technologies and advancements in medical research.
Wang Chen, Vice President of the CAE, gave a welcome speech at the opening ceremony held on the afternoon of November 23, and John I. Gallin, former director of the NIH Clinical Centre in the US, delivered a video speech. CAE member Yang Shengli, also director of the symposium’s organizing committee, presided over the opening ceremony. Speakers who made presentations at the plenary session included Wang and Peter J. Barnes.
In the forum “New Advances in the Diagnosis and Treatment of Major Chronic Diseases - Paradigm Change in Complex Chronic Disease Research", more than 20 experts from over ten institutions held discussions on various topics such as respiratory diseases, metabolic diseases, cardiovascular diseases, tumors, innovative drugs and COVID-19.
The ISCTM, successfully held for eight sessions in Shanghai since 2010, has developed into a high-level academic event with international influence. It has effectively promoted international exchanges and cooperation in the fields of medical treatment and healthcare, and facilitated an interdisciplinary approach in research and application of results, providing a valuable platform for exchanges and high-quality development of clinical and translational medicine.